Because G3BP2 inhibition decreased PD‐L1 expression, we next investigated whether the decrease in tumor growth after genetic or C108 suppression of G3BP2 observed in our previous experiment was related to an enhanced antitumor immune response. The gene discussed is CD274; the disease is neoplasm.